Siemens CFO Ralf Thomas expressed the company's continued interest in splitting off Siemens Healthineers, its healthcare division. He said Siemens is exploring three potential paths: a spinoff, an initial public offering or a reverse merger with a public company. 

Harvard Pilgrim Health Care signed an outcomes-based refund contract with Amgen pertaining to evolocumab (Repatha), the company’s cholesterol-lowering medication.

An analysis of Open Payments reports found that 74.9 percent of cardiologists in the U.S. received industry-related payments in 2015, representing the highest proportion within physician specialties.

Adults who had favorable cardiovascular health in early middle age lived an average of 3.9 years longer, survived 4.5 years longer before developing a chronic illness and saved nearly $18,000 in Medicare costs compared with those with two or more risk factors at middle age, according to a longitudinal cohort study.

During the first quarter of 2017, Boston Scientific’s sales increased 10 percent to $2.16 billion compared with the same time period last year. The company also reported GAAP earnings of $0.21 per share, up from $0.15 per share in the first quarter of 2016.

The Partners HealthCare System and Brigham and Women’s Hospital agreed to pay $10 million to resolve allegations that the hospital’s stem cell research laboratory fraudulently obtained grant funding.

CardioNet agreed to pay $2.5 million and implement a corrective action plan to settle allegations of noncompliance with HIPAA privacy and security rules.

A jury in Los Angeles this week awarded former Cardiovascular Systems sales manager Steven Babyak more than $25 million in damages related to a whistleblower and wrongful termination lawsuit he filed against the company.